[Progress in the contraceptive use of the LH-RH agonist buserelin: intermittent medication with gestagen-induced withdrawal bleeding].

作者: W. Hardt , K. Schmidt-Gollwitzer , J. Nevinny-Stickel , M. Schmidt-Gollwitzer

DOI: 10.1055/S-2008-1037177

关键词:

摘要:

参考文章(0)